Fort Washington Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264K Sell
2,093
-139
-6% -$18.3K ﹤0.01% 391
2026
Q1
$311K Hold
2,232
﹤0.01% 376
2025
Q4
$274K Buy
2,232
+44
+2% +$5.35K ﹤0.01% 384
2025
Q3
$243K Buy
2,188
+254
+13% +$28.9K ﹤0.01% 392
2025
Q2
$214K Sell
1,934
-307,957
-99% -$32.8M ﹤0.01% 391
2025
Q1
$34.7M Sell
309,891
-66,156
-18% -$6.83M 0.21% 110
2024
Q4
$34.7M Buy
376,047
+53,617
+17% +$4.83M 0.21% 109
2024
Q3
$27M Buy
322,430
+14,082
+5% +$1.07M 0.16% 124
2024
Q2
$21.2M Buy
308,348
+5,065
+2% +$338K 0.14% 132
2024
Q1
$22.2M Buy
303,283
+52
+0% +$4K 0.14% 131
2023
Q4
$24.6M Buy
303,231
+1,191
+0.4% +$92.7K 0.17% 119
2023
Q3
$22.6M Buy
302,040
+234
+0.1% +$18K 0.17% 124
2023
Q2
$23.3M Sell
301,806
-1,267
-0.4% -$101K 0.17% 130
2023
Q1
$25.1M Buy
303,073
+1,854
+0.6% +$154K 0.19% 118
2022
Q4
$25.9M Sell
301,219
-66,025
-18% -$5.23M 0.2% 111
2022
Q3
$22.7M Hold
367,244
0.19% 119
2022
Q2
$22.7M Buy
367,244
+2,212
+0.6% +$137K 0.17% 123
2022
Q1
$21.7M Buy
365,032
+9,334
+3% +$597K 0.14% 133
2021
Q4
$25.8M Buy
355,698
+84
+0% +$5.79K 0.16% 128
2021
Q3
$24.8M Buy
355,614
+266,178
+298% +$18.7M 0.16% 131
2021
Q2
$6.16M Hold
89,436
0.05% 227
2021
Q1
$5.78M Sell
89,436
-5,033
-5% -$325K 0.06% 228
2020
Q4
$5.5M Buy
94,469
+7,442
+9% +$449K 0.06% 221
2020
Q3
$5.5M Buy
87,027
+182
+0.2% +$12.6K 0.06% 216
2020
Q2
$6.68M Sell
86,845
-55,338
-39% -$4.24M 0.08% 198
2020
Q1
$10.6M Buy
142,183
+5,052
+4% +$349K 0.14% 120
2019
Q4
$8.91M Buy
137,131
+33,688
+33% +$2.19M 0.1% 191
2019
Q3
$6.56M Buy
103,443
+34,386
+50% +$2.25M 0.07% 200
2019
Q2
$4.67M Sell
69,057
-21,173
-23% -$1.39M 0.05% 212
2019
Q1
$5.87M Sell
90,230
-6,800
-7% -$452K 0.07% 198
2018
Q4
$6.07M Sell
97,030
-29,253
-23% -$2.04M 0.07% 184
2018
Q3
$9.75M Sell
126,283
-19,758
-14% -$1.49M 0.1% 185
2018
Q2
$10.3M Sell
146,041
-1,763
-1% -$124K 0.1% 190
2018
Q1
$11.1M Sell
147,804
-28,192
-16% -$2.24M 0.12% 185
2017
Q4
$12.6M Buy
175,996
+857
+0.5% +$65.1K 0.13% 194
2017
Q3
$14.2M Buy
175,139
+6,757
+4% +$517K 0.22% 76
2017
Q2
$11.9M Sell
168,382
-1,489
-0.9% -$99.1K 0.19% 80
2017
Q1
$11.5M Sell
169,871
-6,611
-4% -$465K 0.18% 82
2016
Q4
$12.6M Buy
176,482
+142,028
+412% +$10.6M 0.21% 73
2016
Q3
$2.73M Sell
34,454
-8,576
-20% -$697K 0.05% 176
2016
Q2
$3.59M Sell
43,030
-7,147
-14% -$634K 0.07% 157
2016
Q1
$4.61M Sell
50,177
-8,960
-15% -$808K 0.09% 131
2015
Q4
$5.99M Sell
59,137
-5,879
-9% -$612K 0.12% 116
2015
Q3
$6.38M Buy
65,016
+18,780
+41% +$2.09M 0.13% 111
2015
Q2
$5.41M Sell
46,236
-3,889
-8% -$425K 0.1% 127
2015
Q1
$4.92M Sell
50,125
-1,582
-3% -$161K 0.1% 132
2014
Q4
$4.87M Buy
51,707
+7,486
+17% +$774K 0.1% 136
2014
Q3
$4.71M Sell
44,221
-96,462
-69% -$9.45M 0.1% 142
2014
Q2
$11.7M Buy
140,683
+119,908
+577% +$9.33M 0.23% 101
2014
Q1
$1.47M Sell
20,775
-900
-4% -$70.6K 0.03% 232
2013
Q4
$1.63M Sell
21,675
-1,713
-7% -$119K 0.04% 287
2013
Q3
$1.47M Buy
23,388
+638
+3% +$38.1K 0.04% 298
2013
Q2
$1.17M Buy
+22,750
New +$1.19M 0.03% 298

Other funds holding GILD

Fort Washington Investment Advisors's GILD Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Gilead Sciences (GILD) stake by 6.2% in Q2 2026, selling an estimated $18.3K and leaving 2,093 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Fort Washington Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.7M in Q4 2024. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fort Washington Investment Advisors held 2,093 shares of Gilead Sciences worth $264K as of Q2 2026.
  • Fort Washington Investment Advisors sold 139 Gilead Sciences shares in Q2 2026, an estimated $18.3K.
  • Gilead Sciences made up ﹤0.01% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #391 holding.
  • Fort Washington Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Fort Washington Investment Advisors's Gilead Sciences position peaked at $34.7M in Q4 2024.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.